Cerenome, Inc. CNSY
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -60.02% | -24.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -60.02% | -24.80% | |||
| Cost of Revenue | 48.87% | -2.58% | |||
| Gross Profit | -109.80% | -16.71% | |||
| SG&A Expenses | -1.50% | 26.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.21% | 14.60% | |||
| Operating Income | -27.22% | -23.98% | |||
| Income Before Tax | -29.66% | -21.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -29.66% | -21.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -29.66% | -21.58% | |||
| EBIT | -27.22% | -23.98% | |||
| EBITDA | -27.01% | -25.48% | |||
| EPS Basic | -24.91% | -0.74% | |||
| Normalized Basic EPS | -24.91% | -0.76% | |||
| EPS Diluted | -24.91% | 0.56% | |||
| Normalized Diluted EPS | -24.91% | -0.76% | |||
| Average Basic Shares Outstanding | 3.80% | 20.68% | |||
| Average Diluted Shares Outstanding | 3.80% | 20.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||